Labshake search

351 - 400 of 2811 citations for Recombinant Human ROBO4 Protein since 2019

• The CARD8 inflammasome drives CD4⁺ T-cell depletion in HIV-1 infection

  Qiankun Wang, Liang Shan, bioRxiv - Microbiology 2023

  Quote: ... anti-human CD4-PECy7 (BioLegend #317414), anti-human CD8-BUV395 (BD Biosciences #563795) ...
• Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis

  Emma Schuster, et al., bioRxiv - Cancer Biology 2023

  Quote: ... Sema4A APC (human/mouse Biolegend #148406). Cells were washed 2x in wash buffer and run for analysis on a fluorescence-associated cell sorting (FACS ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... APC anti-human CD206 (321109, Biolegend), APC anti-human CD86 (374207 ...
• Selective Inhibition of Interleukin-2 Inducible T Cell Kinase (ITK) Enhances Anti-Tumor Immunity in Association with Th1-skewing, Cytotoxic T cell Activation, and Reduced T Cell Exhaustion

  Lih-Yun Hsu, et al., bioRxiv - Cancer Biology 2023

  Quote: ... or against human CD3 (OKT3, Biolegend), CD4 (RPA-T4 ...
• Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis

  Linnea Z. Drexhage, et al., bioRxiv - Cell Biology 2023

  Quote: ... and anti-human CD8 (SK1, Biolegend) were used at 1:100 ...
• Selective Inhibition of Interleukin-2 Inducible T Cell Kinase (ITK) Enhances Anti-Tumor Immunity in Association with Th1-skewing, Cytotoxic T cell Activation, and Reduced T Cell Exhaustion

  Lih-Yun Hsu, et al., bioRxiv - Cancer Biology 2023

  Quote: ... anti-human IL-4 (OA19A66, Biolegend) and anti-human IL-5 (TRFK5 ...
• Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis

  Linnea Z. Drexhage, et al., bioRxiv - Cell Biology 2023

  Quote: ... anti-human MUC1-PE (16A, Biolegend) at 2 µg/mL ...
• Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis

  Linnea Z. Drexhage, et al., bioRxiv - Cell Biology 2023

  Quote: ... anti-human MUC24-PE (67D2, Biolegend), 0.5 µg/mL ...
• Microglia at Sites of Atrophy Restrict the Progression of Retinal Degeneration via Galectin-3 and Trem2 Interactions

  Chen Yu, et al., bioRxiv - Immunology 2023

  Quote: ... BV785 anti-human CD45 (Biolegend #304048), BV510 anti-human CD11B (Biolegend #562950 ...
• Microglia at Sites of Atrophy Restrict the Progression of Retinal Degeneration via Galectin-3 and Trem2 Interactions

  Chen Yu, et al., bioRxiv - Immunology 2023

  Quote: ... BV510 anti-human CD11B (Biolegend #562950) and processed with single-cell multiplexing kit (BD) ...
• Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis

  Linnea Z. Drexhage, et al., bioRxiv - Cell Biology 2023

  Quote: ... anti-human CD4 (RAPA-T4, Biolegend) and anti-human CD8 (SK1 ...
• C-terminal amides mark proteins for degradation via SCF/FBXO31

  Matthias Muhar, et al., bioRxiv - Cell Biology 2023

  Quote: ... (APC-anti-human-CD55[JS11], Biolegend). After 20 minutes of incubation on ice ...
• Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including BQ and XBB lineages

  Ling Li, et al., bioRxiv - Immunology 2023

  Quote: ... human IgD-perCP/Cy5.5 (BioLegend, 348207), anti-His-FITC (Proteintech ...
• Eta-secretase-like processing of the amyloid precursor protein (APP) by RHBDL4

  Penalva Ylauna Christine Megane, et al., bioRxiv - Biochemistry 2023

  Quote: ... 6E10 (human Aβ region-specific, Biolegend), 2E9 (epitope as determined by Willem et al. ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-human CD69 FITC (310904; BioLegend) and anti-human CD25 BV421 (302630 ...
• Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice

  Tuancheng Feng, Huan Du, Fenghua Hu, bioRxiv - Neuroscience 2023

  Quote: ... rat anti-human Tau (BioLegend, A16103A), Phospho-Tau (Ser404 ...
• On-chip human lymph node stromal network for evaluating dendritic cell and T-cell trafficking

  Brian J. Kwee, Adovi Akue, Kyung E. Sung, bioRxiv - Bioengineering 2023

  Quote: ... anti-human CD45 (BioLegend, 2D1, PE), and anti-human podoplanin (BioLegend ...
• CD82 expression marks the endothelium to hematopoietic transition at the onset of blood specification in human

  Sara Menegatti, et al., bioRxiv - Developmental Biology 2023

  Quote: ... PE-conjugated anti-human CD144 (BioLegend), PerCP-eF710-conjugated anti-human CD43 (Thermo Fisher Scientific ...
• Cysteine-Rich Intestinal Protein 1 is a Novel Surface Marker for Myometrial Stem/Progenitor Cells

  Emmanuel N. Paul, et al., bioRxiv - Developmental Biology 2023

  Quote: ... Mouse anti-human SUSD2 (Biolegend #327401) and Mouse anti-human PECAM1 (Abcam ...
• Validation of ligand tetramers for the detection of antigen-specific lymphocytes

  Kristin S. Fitzpatrick, et al., bioRxiv - Immunology 2022

  Quote: ... anti-human CD19 FITC (HIB19, BioLegend), anti-mouse B220/CD45R PerCP (RA3-6B2 ...
• Validation of ligand tetramers for the detection of antigen-specific lymphocytes

  Kristin S. Fitzpatrick, et al., bioRxiv - Immunology 2022

  Quote: ... anti-human HLA-A2 (BB7.2, BioLegend), anti-human HLA-ABC (W6/32 ...
• Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis

  Emma Schuster, et al., bioRxiv - Cancer Biology 2023

  Quote: ... Sema4A PE (human/mouse, BioLegend #148404), Sema4A APC (human/mouse Biolegend #148406) ...
• AIDS virus-neutralizing antibody induction reciprocal to a PI3K gain-of-function disease

  Hiroyuki Yamamoto, Tetsuro Matano, bioRxiv - Immunology 2023

  Quote: ... anti-human CXCR4-APC (12G5, BioLegend), BST2-Alexa 647 (RS38E ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... FITC anti-human CD14 (301803, Biolegend) and APC anti-humanCD11B (301309 ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... PE anti-human CD80 (305208, Biolegend), PE anti-human CD163 (333605 ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... PE anti-human CD163 (333605, Biolegend), FITC anti-human CD14 (301803 ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... APC anti-human CD86 (374207, Biolegend), PE anti-human CD80 (305208 ...
• Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis

  Emma Schuster, et al., bioRxiv - Cancer Biology 2023

  Quote: ... Sema4A PE (human/mouse, BioLegend #148404). Cells were then run through BD FACSMelody Cell Sorter and cells were collected based on gated populations ...
• Differential neural circuit vulnerability to β-amyloid and tau pathologies in novel Alzheimer’s disease mice

  Maria Dolores Capilla-López, et al., bioRxiv - Neuroscience 2023

  Quote: ... human Aβ (6E10) (BioLegend, SIG-39320), synaptophysin (Sigma ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-human CD8a PerCP (300922; BioLegend), anti-human CD69 FITC (310904 ...
• Emergence of a senescent and inflammatory pulmonary CD4⁺ T cell population prior to lung allograft failure

  Sajad Moshkelgosha, et al., bioRxiv - Immunology 2023

  Quote: ... APC-conjugated anti-human PD1 (BioLegend); PE/Cy7-conjugated anti-human CD57 ...
• Lactose blocks intercellular spreading of Galectin-1 from cancer cells to T-cells and activates tumor immunological control

  Yu Hong, et al., bioRxiv - Immunology 2023

  Quote: ... APC anti-human CD8α (BioLegend, 300912), PE anti-human IFNγ (BioLegend ...
• Lactose blocks intercellular spreading of Galectin-1 from cancer cells to T-cells and activates tumor immunological control

  Yu Hong, et al., bioRxiv - Immunology 2023

  Quote: ... PE anti-human IFNγ (BioLegend, 506507), and FITC anti-mouse TCR Vα2 (BioLegend ...
• Targetable leukemia dependency on noncanonical PI3Kγ signaling

  Qingyu Luo, et al., bioRxiv - Cancer Biology 2023

  Quote: ... FITC anti-human CD14 (325604; BioLegend), and APC/Cyanine7 anti-mouse/human CD11b (101226 ...
• Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic Antibodies

  William N. Feist, et al., bioRxiv - Bioengineering 2024

  Quote: ... anti-human IgD (BioLegend, cat.: 348232), and anti-human IgM (BD ...
• Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic Antibodies

  William N. Feist, et al., bioRxiv - Bioengineering 2024

  Quote: ... anti-human CD27 (BioLegend, cat.: 302832), anti-human CD38 (BD ...
• Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic Antibodies

  William N. Feist, et al., bioRxiv - Bioengineering 2024

  Quote: ... anti-human CD3 (Biolegend, cat.: 300328), and viability dye Ghost Dye™ Violet 540 (Tonbo Bioscience ...
• Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic Antibodies

  William N. Feist, et al., bioRxiv - Bioengineering 2024

  Quote: ... anti-human CD19 (Biolegend, cat.: 302212), anti-human CD3 (Biolegend ...
• Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic Antibodies

  William N. Feist, et al., bioRxiv - Bioengineering 2024

  Quote: ... anti-human CD45 (Biolegend, cat.: 368540), anti-human HLA-ABC (Biolegend ...
• SAP expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis

  Yevgeniya Gartshteyn, et al., bioRxiv - Immunology 2023

  Quote: ... and anti-human SLAMF3 (BioLegend #326109).
• PD-1 signaling uncovers a pathogenic subset of T cells in inflammatory arthritis

  Johanna Straube, et al., bioRxiv - Immunology 2023

  Quote: ... mouse anti-human CD28 antibody (BioLegend), recombinant human PD-L1 human IgG1 Fc chimera protein (R&D Systems) ...
• A longevity-specific bank of induced pluripotent stem cells from centenarians and their offspring

  Todd W. Dowrey, et al., bioRxiv - Molecular Biology 2024

  Quote: ... blocked with Human FcBlock (BioLegend 422301) and stained with a panel of 40 fluorescent reagents (Supplementary Table 1 ...
• Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection

  Leila B Giron, et al., bioRxiv - Microbiology 2023

  Quote: ... TotalSeq-B human CITEseq antibodies (BioLegend) used to subtype immune cells in the downstream data were ...
• Direct delivery of stabilized Cas-embedded base editors achieves efficient and accurate editing of clinically relevant targets

  Jeong Min Lee, et al., bioRxiv - Biochemistry 2024

  Quote: ... and anti-human CD3 (BioLegend, # 300420). Samples were acquired and recorded on a BD FACSAria II and data were analyzed with FlowJo™ software.
• Metabolic Deficiencies Underlie Plasmacytoid Dendritic Cell Exhaustion After Viral Infection

  Trever T. Greene, et al., bioRxiv - Immunology 2024

  Quote: ... anti-human CD56 (MEM-188, BioLegend), HLA-DR (L243 ...
• AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer

  Meriem Belabed, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD80 (clone W17149D, BioLegend), anti-human CD83 (clone HB15e ...
• AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer

  Meriem Belabed, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD123 (clone 6H6, BioLegend), anti-human CLEC9A (clone 8F9 ...
• AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer

  Meriem Belabed, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD83 (clone HB15e, BioLegend), anti-human CD86 (clone BU63 ...
• AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer

  Meriem Belabed, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD86 (clone BU63, BioLegend), anti-human PD-L1 (clone 29E2A3 ...
• AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer

  Meriem Belabed, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD1C (clone L161, BioLegend), anti-human CD123 (clone 6H6 ...